Sign Out
Therapeutic Indication(s): Ostivea 3 mg/3ml Solution for IV Injection in Pre-filled Syringe is indicated for the treatment of postmenopausal osteoporosis, to reduce the risk of fractures. Efficacy on femoral neck fractures has not been established.
Treatment of Osteoporosis: Osteoporosis may be confirmed by the finding of low bone mass (T score < -2.0 SD) and the presence or history of osteoporotic fracture, or a low bone mass (T-score < -2.5 SD) in the absence of documented pre-existing osteoporotic fracture.
